Cognitive and negative symptoms in schizophrenia with L-Carnosine adjuvant therapy - A randomized double-blind placebo-controlled study.
- 2023-03-22
- RCT
- Pharmacology research & perspectives 11(2)
- Hema Tharoor
- Sindhu Maran
- Antra K Chandan
- Manikandan Pari
- Shruti Rao
- Jothilakshmi Durairaj
- PubMed: 36946070
- DOI: 10.1002/prp2.1074
- High evidence
- Clinical
The attention scores (p = .023) showed significant differences in patients receiving 800 mg of L-Carnosine at the end of the study.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 400 mg/day for first 3 months, then 800 mg/day from week 13 to week 24